BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Durán-Lobato M, Niu Z, Alonso MJ. Oral Delivery of Biologics for Precision Medicine. Adv Mater 2020;32:e1901935. [PMID: 31222910 DOI: 10.1002/adma.201901935] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 23.5] [Reference Citation Analysis]
Number Citing Articles
1 McClements DJ. Nano-enabled personalized nutrition: Developing multicomponent-bioactive colloidal delivery systems. Adv Colloid Interface Sci 2020;282:102211. [PMID: 32721626 DOI: 10.1016/j.cis.2020.102211] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
2 Quattrini F, Berrecoso G, Crecente-Campo J, Alonso MJ. Asymmetric flow field-flow fractionation as a multifunctional technique for the characterization of polymeric nanocarriers. Drug Deliv Transl Res 2021;11:373-95. [PMID: 33521866 DOI: 10.1007/s13346-021-00918-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li Z, Wang Y, Liu J, Rawding P, Bu J, Hong S, Hu Q. Chemically and Biologically Engineered Bacteria-Based Delivery Systems for Emerging Diagnosis and Advanced Therapy. Adv Mater 2021;33:e2102580. [PMID: 34347325 DOI: 10.1002/adma.202102580] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
4 Sun L, Le Z, He S, Liu J, Liu L, Leong KW, Mao HQ, Liu Z, Chen Y. Flash Fabrication of Orally Targeted Nanocomplexes for Improved Transport of Salmon Calcitonin across the Intestine. Mol Pharm 2020;17:757-68. [PMID: 32011888 DOI: 10.1021/acs.molpharmaceut.9b00827] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
5 Chen W, Wainer J, Ryoo SW, Qi X, Chang R, Li J, Lee SH, Min S, Wentworth A, Collins JE, Tamang S, Ishida K, Hayward A, Langer R, Traverso G. Dynamic omnidirectional adhesive microneedle system for oral macromolecular drug delivery. Sci Adv 2022;8:eabk1792. [PMID: 34985942 DOI: 10.1126/sciadv.abk1792] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Wang J, Chin D, Poon C, Mancino V, Pham J, Li H, Ho PY, Hallows KR, Chung EJ. Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease. J Control Release 2021;329:1198-209. [PMID: 33127449 DOI: 10.1016/j.jconrel.2020.10.047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
7 De Anda-flores Y, Carvajal-millan E, Campa-mada A, Lizardi-mendoza J, Rascon-chu A, Tanori-cordova J, Martínez-lópez AL. Polysaccharide-Based Nanoparticles for Colon-Targeted Drug Delivery Systems. Polysaccharides 2021;2:626-47. [DOI: 10.3390/polysaccharides2030038] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Wu P, Zhang H, Yin Y, Sun M, Mao S, Chen H, Deng Y, Chen S, Li S, Sun B. Engineered EGCG-Containing Biomimetic Nanoassemblies as Effective Delivery Platform for Enhanced Cancer Therapy. Adv Sci (Weinh) 2022;9:e2105894. [PMID: 35486032 DOI: 10.1002/advs.202105894] [Reference Citation Analysis]
9 Cao Y, Rewatkar P, Wang R, Hasnain SZ, Popat A, Kumeria T. Nanocarriers for oral delivery of biologics: small carriers for big payloads. Trends Pharmacol Sci 2021;42:957-72. [PMID: 34593258 DOI: 10.1016/j.tips.2021.08.005] [Reference Citation Analysis]
10 Chu JN, Traverso G. Foundations of gastrointestinal-based drug delivery and future developments. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34785786 DOI: 10.1038/s41575-021-00539-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Qiu H, Gong H, Bao Y, Jiang H, Tong W. Reactive oxygen species-scavenging hollow MnO2 nanozymes as carriers to deliver budesonide for synergistic inflammatory bowel disease therapy. Biomater Sci 2021. [PMID: 34882157 DOI: 10.1039/d1bm01525g] [Reference Citation Analysis]
12 Li L, Pan H, Pang G, Lang H, Shen Y, Sun T, Zhang Y, Liu J, Chang J, Kang J, Zheng H, Wang H. Precise Thermal Regulation of Engineered Bacteria Secretion for Breast Cancer Treatment In Vivo. ACS Synth Biol 2022;11:1167-77. [PMID: 35175748 DOI: 10.1021/acssynbio.1c00452] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Niu Z, Thielen I, Loveday SM, Singh H. Emulsions Stabilised by Polyethylene Glycol (PEG) 40 Stearate and Lactoferrin for Protection of Lactoferrin during In Vitro Digestion. Food Biophysics 2021;16:40-7. [DOI: 10.1007/s11483-020-09647-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Miao YB, Lin YJ, Chen KH, Luo PK, Chuang SH, Yu YT, Tai HM, Chen CT, Lin KJ, Sung HW. Engineering Nano- and Microparticles as Oral Delivery Vehicles to Promote Intestinal Lymphatic Drug Transport. Adv Mater 2021;33:e2104139. [PMID: 34596293 DOI: 10.1002/adma.202104139] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
15 McCartney F, Rosa M, Brayden DJ. Evaluation of Sucrose Laurate as an Intestinal Permeation Enhancer for Macromolecules: Ex Vivo and In Vivo Studies. Pharmaceutics 2019;11:E565. [PMID: 31683652 DOI: 10.3390/pharmaceutics11110565] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
16 Cummins G. Smart pills for gastrointestinal diagnostics and therapy. Adv Drug Deliv Rev 2021;177:113931. [PMID: 34416311 DOI: 10.1016/j.addr.2021.113931] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
17 Mühlberg E, Burtscher M, Umstätter F, Fricker G, Mier W, Uhl P. Trends in liposomal nanocarrier strategies for the oral delivery of biologics. Nanomedicine (Lond) 2021;16:1813-32. [PMID: 34269068 DOI: 10.2217/nnm-2021-0177] [Reference Citation Analysis]
18 Melocchi A, Uboldi M, Briatico-Vangosa F, Moutaharrik S, Cerea M, Foppoli A, Maroni A, Palugan L, Zema L, Gazzaniga A. The Chronotopic™ System for Pulsatile and Colonic Delivery of Active Molecules in the Era of Precision Medicine: Feasibility by 3D Printing via Fused Deposition Modeling (FDM). Pharmaceutics 2021;13:759. [PMID: 34065414 DOI: 10.3390/pharmaceutics13050759] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Haddadzadegan S, Dorkoosh F, Bernkop-Schnürch A. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers. Adv Drug Deliv Rev 2022;182:114097. [PMID: 34999121 DOI: 10.1016/j.addr.2021.114097] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
20 Li B, Li X, Chu X, Lou P, Yuan Y, Zhuge A, Zhu X, Shen Y, Pan J, Zhang L, Li L, Wu Z. Micro-ecology restoration of colonic inflammation by in-Situ oral delivery of antibody-laden hydrogel microcapsules. Bioactive Materials 2021. [DOI: 10.1016/j.bioactmat.2021.12.022] [Reference Citation Analysis]
21 Liu C, Chen B, Shi W, Huang W, Qian H. Ionic Liquids for Enhanced Drug Delivery: Recent Progress and Prevailing Challenges. Mol Pharm 2022. [PMID: 35274963 DOI: 10.1021/acs.molpharmaceut.1c00960] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Liu P, Li Y, Wang R, Ren F, Wang X. Oxidative Stress and Antioxidant Nanotherapeutic Approaches for Inflammatory Bowel Disease. Biomedicines 2022;10:85. [DOI: 10.3390/biomedicines10010085] [Reference Citation Analysis]
23 Mobasheri A. Neuroscience and Neuroimmunology Solutions for Osteoarthritis Pain: Biological Drugs, Growth Factors, Peptides and Monoclonal Antibodies Targeting Peripheral Nerves. NeuroSci 2021;2:45-58. [DOI: 10.3390/neurosci2010003] [Reference Citation Analysis]
24 Zhang Y, Li M, Du G, Chen X, Sun X. Advancedoral vaccine delivery strategies for improving the immunity. Adv Drug Deliv Rev 2021;177:113928. [PMID: 34411689 DOI: 10.1016/j.addr.2021.113928] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
25 Wang ZH, Chu M, Yin N, Huang W, Liu W, Zhang Z, Liu J, Shi J. Biological chemotaxis-guided self-thermophoretic nanoplatform augments colorectal cancer therapy through autonomous mucus penetration. Sci Adv 2022;8:eabn3917. [PMID: 35767627 DOI: 10.1126/sciadv.abn3917] [Reference Citation Analysis]
26 Zeng Z, He X, Li C, Lin S, Chen H, Liu L, Feng X. Oral delivery of antioxidant enzymes for effective treatment of inflammatory disease. Biomaterials 2021;271:120753. [PMID: 33725585 DOI: 10.1016/j.biomaterials.2021.120753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 Hu X, Yang G, Chen S, Luo S, Zhang J. Biomimetic and bioinspired strategies for oral drug delivery. Biomater Sci 2020;8:1020-44. [PMID: 31621709 DOI: 10.1039/c9bm01378d] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
28 Zhu Q, Chen Z, Paul PK, Lu Y, Wu W, Qi J. Oral delivery of proteins and peptides: Challenges, status quo and future perspectives. Acta Pharm Sin B 2021;11:2416-48. [PMID: 34522593 DOI: 10.1016/j.apsb.2021.04.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
29 Lu Y, Wang C, Jiang B, Sun CC, Hoag SW. Effects of compaction and storage conditions on stability of intravenous immunoglobulin - Implication on developing oral tablets of biologics. Int J Pharm 2021;604:120737. [PMID: 34048928 DOI: 10.1016/j.ijpharm.2021.120737] [Reference Citation Analysis]
30 Xing L, Zheng Y, Yu Y, Wu R, Liu X, Zhou R, Huang Y. Complying with the physiological functions of Golgi apparatus for secretory exocytosis facilitated oral absorption of protein drugs. J Mater Chem B 2021;9:1707-18. [PMID: 33496710 DOI: 10.1039/d0tb02848g] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Tong T, Wang L, You X, Wu J. Nano and microscale delivery platforms for enhanced oral peptide/protein bioavailability. Biomater Sci 2020;8:5804-23. [PMID: 33016274 DOI: 10.1039/d0bm01151g] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
32 Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 2021;20:101-24. [PMID: 33277608 DOI: 10.1038/s41573-020-0090-8] [Cited by in Crossref: 182] [Cited by in F6Publishing: 173] [Article Influence: 91.0] [Reference Citation Analysis]
33 Altaani BM, Almaaytah AM, Dadou S, Alkhamis K, Daradka MH, Hananeh W. Oral Delivery of Teriparatide Using a Nanoemulsion System: Design, in Vitro and in Vivo Evaluation. Pharm Res 2020;37:80. [PMID: 32253527 DOI: 10.1007/s11095-020-02793-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Ahadian S, Finbloom JA, Mofidfar M, Diltemiz SE, Nasrollahi F, Davoodi E, Hosseini V, Mylonaki I, Sangabathuni S, Montazerian H, Fetah K, Nasiri R, Dokmeci MR, Stevens MM, Desai TA, Khademhosseini A. Micro and nanoscale technologies in oral drug delivery. Adv Drug Deliv Rev 2020;157:37-62. [PMID: 32707147 DOI: 10.1016/j.addr.2020.07.012] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 21.0] [Reference Citation Analysis]
35 Coffey JW, Gaiha GD, Traverso G. Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics. Annu Rev Pharmacol Toxicol 2021;61:517-40. [PMID: 32466690 DOI: 10.1146/annurev-pharmtox-030320-092348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
36 Cao Z, Lin S, Liu J. Bacteria-Based Microdevices for the Oral Delivery of Macromolecules. Pharmaceutics 2021;13:1610. [PMID: 34683903 DOI: 10.3390/pharmaceutics13101610] [Reference Citation Analysis]
37 Elshaer D, Moniruzzaman M, Ong YT, Qu Z, Schreiber V, Begun J, Popat A. Facile synthesis of dendrimer like mesoporous silica nanoparticles to enhance targeted delivery of interleukin-22. Biomater Sci 2021;9:7402-11. [PMID: 34709241 DOI: 10.1039/d1bm01352a] [Reference Citation Analysis]
38 Li P, Ford L, Haque S, McInerney MP, Williams HD, Scammells PJ, Thompson PE, Jannin V, Porter CJH, Benameur H, Pouton CW. Lipophilic Salts and Lipid-Based Formulations: Enhancing the Oral Delivery of Octreotide. Pharm Res 2021;38:1125-37. [PMID: 34100217 DOI: 10.1007/s11095-021-03063-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Zhang J, Liu X, Lin J, Bao X, Peng J, Gong Z, Luan X, Chen Y. Biomimetic engineered nanocarriers inspired by viruses for oral-drug delivery. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121979] [Reference Citation Analysis]
40 Liang W, Pan HW, Vllasaliu D, Lam JKW. Pulmonary Delivery of Biological Drugs. Pharmaceutics 2020;12:E1025. [PMID: 33114726 DOI: 10.3390/pharmaceutics12111025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
41 Balusamy B, Celebioglu A, Senthamizhan A, Uyar T. Progress in the design and development of "fast-dissolving" electrospun nanofibers based drug delivery systems - A systematic review. J Control Release 2020;326:482-509. [PMID: 32721525 DOI: 10.1016/j.jconrel.2020.07.038] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
42 Singh A, Kaur K, Mandal UK, Narang RK. Nanoparticles as Budding Trends in Colon Drug Delivery for the Management of Ulcerative Colitis. CNANOM 2020;10:225-47. [DOI: 10.2174/2468187310999200621200615] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
43 Carneiro DC, Fernandez LG, Monteiro-Cunha JP, Benevides RG, Cunha Lima ST. A patent review of the antimicrobial applications of lectins: Perspectives on therapy of infectious diseases. J Appl Microbiol 2021. [PMID: 34416098 DOI: 10.1111/jam.15263] [Reference Citation Analysis]
44 Alotaibi BS, Buabeid M, Ibrahim NA, Kharaba ZJ, Ijaz M, Murtaza G. Recent strategies driving oral biologic administration. Expert Rev Vaccines 2021;:1-15. [PMID: 34612121 DOI: 10.1080/14760584.2021.1990044] [Reference Citation Analysis]
45 Ma Z, Li B, Peng J, Gao D. Recent Development of Drug Delivery Systems through Microfluidics: From Synthesis to Evaluation. Pharmaceutics 2022;14:434. [DOI: 10.3390/pharmaceutics14020434] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Santalices I, Vázquez-Vázquez C, Santander-Ortega MJ, Lozano V, Araújo F, Sarmento B, Shrestha N, Préat V, Chenlo M, Alvarez CV, Benetti F, Cuñarro J, Tovar S, Torres D, Alonso MJ. A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin. Drug Deliv Transl Res 2021;11:524-45. [PMID: 33575972 DOI: 10.1007/s13346-021-00920-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Hoang HT, Vu TT, Karthika V, Jo S, Jo Y, Seo J, Oh C, Park S, Lim KT. Dual cross-linked chitosan/alginate hydrogels prepared by Nb-Tz ‘click’ reaction for pH responsive drug delivery. Carbohydrate Polymers 2022;288:119389. [DOI: 10.1016/j.carbpol.2022.119389] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
48 Lee SH, Bajracharya R, Min JY, Han JW, Park BJ, Han HK. Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements. Pharmaceutics 2020;12:E68. [PMID: 31952340 DOI: 10.3390/pharmaceutics12010068] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 18.0] [Reference Citation Analysis]
49 Hu Y, Hu S, Zhang S, Dong S, Hu J, Kang L, Yang X. A double-layer hydrogel based on alginate-carboxymethyl cellulose and synthetic polymer as sustained drug delivery system. Sci Rep 2021;11:9142. [PMID: 33911150 DOI: 10.1038/s41598-021-88503-1] [Reference Citation Analysis]
50 Zhong D, Zhang D, Chen W, He J, Ren C, Zhang X, Kong N, Tao W, Zhou M. Orally deliverable strategy based on microalgal biomass for intestinal disease treatment. Sci Adv 2021;7:eabi9265. [PMID: 34818040 DOI: 10.1126/sciadv.abi9265] [Reference Citation Analysis]
51 Durán-Lobato M, López-Estévez AM, Cordeiro AS, Dacoba TG, Crecente-Campo J, Torres D, Alonso MJ. Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape. Adv Drug Deliv Rev 2021;176:113899. [PMID: 34314784 DOI: 10.1016/j.addr.2021.113899] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
52 Lin S, Wu F, Cao Z, Liu J. Advances in Nanomedicines for Interaction with the Intestinal Barrier. Advanced NanoBiomed Research. [DOI: 10.1002/anbr.202100147] [Reference Citation Analysis]